CDKN2A is the major susceptible gene in multiple primary melanoma patients [146,169]; it acts as a tumor suppressor gene, negatively regulating G1-S cell-cycle progression and promoting cellular senescence. This evidence concerns the gene CDKN2A and melanoma.